Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 23 01 2024
accepted: 17 06 2024
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: epublish

Résumé

It is unknown how intestinal B cell populations and B cell receptor (BCR) repertoires are established and maintained over time in humans. Following intestinal transplantation (ITx), surveillance ileal mucosal biopsies provide a unique opportunity to map the dynamic establishment of recipient gut lymphocyte populations in immunosuppressed conditions. Using polychromatic flow cytometry that includes HLA allele group-specific antibodies distinguishing donor from recipient cells along with high throughput BCR sequencing, we tracked the establishment of recipient B cell populations and BCR repertoire in the allograft mucosa of ITx recipients. We confirm the early presence of naïve donor B cells in the circulation (donor age range: 1-14 years, median: 3 years) and, for the first time, document the establishment of recipient B cell populations, including B resident memory cells, in the intestinal allograft mucosa (recipient age range at the time of transplant: 1-44 years, median: 3 years). Recipient B cell repopulation of the allograft was most rapid in infant (<1 year old)-derived allografts and, unlike T cell repopulation, did not correlate with rejection rates. While recipient memory B cell populations were increased in graft mucosa compared to circulation, naïve recipient B cells remained detectable in the graft mucosa for years. Comparisons of peripheral and intra-mucosal B cell repertoires in the absence of rejection (recipient age range at the time of transplant: 1-9 years, median: 2 years) revealed increased BCR mutation rates and clonal expansion in graft mucosa compared to circulating B cells, but these parameters did not increase markedly after the first year post-transplant. Furthermore, clonal mixing between the allograft mucosa and the circulation was significantly greater in ITx recipients, even years after transplantation, than in deceased adult donors. In available pan-scope biopsies from pediatric recipients, we observed higher percentages of naïve recipient B cells in colon allograft compared to small bowel allograft and increased BCR overlap between native colon vs colon allograft compared to that between native colon vs ileum allograft in most cases, suggesting differential clonal distribution in large intestine vs small intestine. Collectively, our data demonstrate intestinal mucosal B cell repertoire establishment from a circulating pool, a process that continues for years without evidence of stabilization of the mucosal B cell repertoire in pediatric ITx patients.

Identifiants

pubmed: 39007142
doi: 10.3389/fimmu.2024.1375486
pmc: PMC11239347
doi:

Substances chimiques

Receptors, Antigen, B-Cell 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1375486

Informations de copyright

Copyright © 2024 Fu, Hsiao, Waffarn, Meng, Long, Frangaj, Jones, Gorur, Shtewe, Li, Muntnich, Rogers, Jiao, Velasco, Matsumoto, Kubota, Wells, Danzl, Ravella, Iuga, Vasilescu, Griesemer, Weiner, Farber, Luning Prak, Martinez, Kato, Hershberg and Sykes.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Jianing Fu (J)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Thomas Hsiao (T)

Department of Human Biology, University of Haifa, Haifa, Israel.

Elizabeth Waffarn (E)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Wenzhao Meng (W)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Katherine D Long (KD)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Kristjana Frangaj (K)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Rebecca Jones (R)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Alaka Gorur (A)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Areen Shtewe (A)

Department of Human Biology, University of Haifa, Haifa, Israel.

Muyang Li (M)

Department of Pathology, Columbia University, New York, NY, United States.

Constanza Bay Muntnich (CB)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Kortney Rogers (K)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Wenyu Jiao (W)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Monica Velasco (M)

Department of Pediatrics, Columbia University, New York, NY, United States.

Rei Matsumoto (R)

Department of Microbiology and Immunology, Columbia University, New York, NY, United States.

Masaru Kubota (M)

Department of Microbiology and Immunology, Columbia University, New York, NY, United States.

Steven Wells (S)

Department of Microbiology and Immunology, Columbia University, New York, NY, United States.

Nichole Danzl (N)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.

Shilpa Ravella (S)

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, United States.

Alina Iuga (A)

Department of Pathology, Columbia University, New York, NY, United States.

Elena-Rodica Vasilescu (ER)

Department of Pathology, Columbia University, New York, NY, United States.

Adam Griesemer (A)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Department of Surgery, Columbia University, New York, NY, United States.

Joshua Weiner (J)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Department of Surgery, Columbia University, New York, NY, United States.

Donna L Farber (DL)

Department of Microbiology and Immunology, Columbia University, New York, NY, United States.
Department of Surgery, Columbia University, New York, NY, United States.

Eline T Luning Prak (ET)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Mercedes Martinez (M)

Department of Pediatrics, Columbia University, New York, NY, United States.

Tomoaki Kato (T)

Department of Surgery, Columbia University, New York, NY, United States.

Uri Hershberg (U)

Department of Human Biology, University of Haifa, Haifa, Israel.

Megan Sykes (M)

Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Department of Microbiology and Immunology, Columbia University, New York, NY, United States.
Department of Surgery, Columbia University, New York, NY, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH